







































Physiological Evidence That the Critical Torque
Is a Phase Transition, Not a Threshold
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ABSTRACT
PETHICK, J., S. L. WINTER, and M. BURNLEY. Physiological Evidence That the Critical Torque Is a Phase Transition, Not a Threshold.
Med. Sci. Sports Exerc., Vol. 52, No. 11, pp. 2390–2401, 2020. Introduction:Distinct physiological responses to exercise occur in the heavy-
and severe-intensity domains, which are separated by the critical power or critical torque (CT). However, how the transition between these
intensity domains actually occurs is not known. We tested the hypothesis that CT is a sudden threshold, with no gradual transition from
heavy- to severe-intensity behavior within the confidence limits associatedwith the CT.Methods: Twelve healthy participants performed four
exhaustive severe-intensity trials for the determination of CT, and four 30-min trials in close proximity to CT (one or two SE above or below
each participant’s CT estimate; CT − 2, CT − 1, CT + 1, CT + 2). Muscle O2 uptake, rectified electromyogram, and torque variability and
complexity were monitored throughout each trial, and maximal voluntary contractions (MVC)with femoral nerve stimulationwere performed
before and after each trial to determine central and peripheral fatigue responses.Results: The rates of change in fatigue-related variables, mus-
cle O2 uptake, electromyogram amplitude, and torque complexity were significantly faster in the severe trials compared with CT − 2. For ex-
ample, the fall in MVC torque was −1.5 ± 0.8 N·m·min−1 in CT − 2 versus –7.9 ± 2.5 N·m·min−1 in the lowest severe-intensity trial (P < 0.05).
Individual analyses showed a low frequency of severe responses even in the circa-CT trials ostensibly above the CT, but also the rare appear-
ance of severe-intensity responses in all circa-CT trials.Conclusions: These data demonstrate that the transition between heavy- and severe-intensity
exercise occurs gradually rather than suddenly. KeyWords:MUSCLE, METABOLIC RATE, NONLINEAR DYNAMICS, FATIGUE
Critical torque (CT), the asymptote of the hyperbolic re-lationship between isometric joint torque and the timeto task failure, is an important functional threshold
(1,2). Above the CT (or, analogously, the critical power
[CP]), it is not possible to achieve a metabolic steady state,
in contrast to exercise performed below it (for reviews, see
Jones et al. [3] and Poole et al. [4]). This metabolic non–
steady state is also associated with the development of periph-
eral fatigue at a rate proportional to the proximity of the torque
or power requirements to the CT or CP (2), with peripheral fa-
tigue developing ~4–5 times faster above CT compared with
that below (2,5). At task failure during contractions above
CT, the degree of peripheral fatigue is similar irrespective of
the duration of the task, suggesting that both the mechanisms
of fatigue and the factors resulting in task failure are common
at these contractile intensities (2,5).
Many physiological variables evidence a threshold change
in behavior once CT/CP is exceeded, including muscle and
pulmonary V̇O2 (6,7), muscle phosphorylcreatine, inorganic
phosphate concentration and pH (8), blood and muscle (lactate)
(9), and muscle fatigue–related variables (2,5,10). Our most
recent work has suggested that CT also represents a critical
threshold for the fatigue-induced loss of knee extensor torque
output complexity (i.e., the structure of fluctuations in the
torque time series) (5). In both health and disease, physiolog-
ical time series complexity has been suggested to be a key
marker of system adaptability (11). In the context of the neu-
romuscular system, a loss of complexity in torque or force
time series with aging, disease, or fatigue has been interpreted
as a loss of motor control (5,12). That it is only above the CT
that the complexity of muscle torque is lost as fatigue develops
suggests that torque complexity also represents a sensitive
marker of the proximity to the CT (5). Thus, from this perspec-
tive, the absence of steady state behavior in muscle metabolism
and muscle V̇O2 (mV̇O2) above the CT/power is mirrored by a
measurable loss of neuromuscular control. Collectively, there-
fore, measures of muscle activity, metabolism, fatigue, and time
series complexity can, individually and/or collectively, provide
sensitive physiological signatures of the proximity of the exer-
cise task to the CT/power.
The threshold nature of the CT is well established, but the
nature of the threshold itself is not. Although CT or CP can
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be expressed to the nearest newton-meter or watt, the confi-
dence limits associated with the point estimate are, at best,
5%–10% of the value of CT/CP (2,10,13). As a result, the in-
tensity at which heavy exercise responses should cease to be
observed is unclear, and investigators usually, and justifiably,
prescribe exercise tasks outside these confidence limits to
avoid such uncertainty. Studies that have been performed at
this critical threshold have returned equivocal results, with
steady-state (6) and non–steady-state responses (14–16) being
observed. However, by definition, performing exercise exactly
at the CP or CT is itself subject to the uncertainty in the param-
eter estimate: 50% of responses are likely to be above CP, and
50% below (17). We state “likely” here because this is, in fact,
supposition: the occurrence of heavy- or severe-intensity be-
havior in close proximity to CT/CP has not yet been systemat-
ically studied.
Distinguishing between behaviors that are consistent with
heavy-intensity exercise versus those that are demonstrably se-
vere is, theoretically, straightforward because tasks performed
below the CT should be fatigueless (1). However, in two sep-
arate studies, we have demonstrated that fatigue does develop
below CT, albeit at a very slow rate (2,5). Moreover, exercise
in the heavy domain is associated with attainment of a delayed
steady state, such that variables will demonstrate a positive
rate of change over time when measured after the initial tran-
sient response (17). Nevertheless, the 4- to 5-fold faster rates
of change observed in metabolic and fatigue-related variables
above versus below the CT, coupled with consistent responses
observed below the CT (2,5,8), provide a clear framework
within which to study exercise responses in relation to the
CT. Figure 1 illustrates purpose of the present investigation,
namely, to characterize the physiological responses to tasks
performed in close proximity to the CT, for which there are cur-
rently no data from our intermittent isometric contraction model.
There are, we contend, two possible patterns of behavior
that could occur in close proximity to the CT: 1) if the CT is
a precise threshold, and the confidence limits associated with
the parameter estimate reflect fitting error in the severe-
intensity predicting trials, then consistent severe-intensity behav-
ior should be observed in close proximity to, but nonetheless
above, the CT; 2) if CT is a precise threshold that varies
day-to-day by an amount represented by the confidence limits,
or if the CT is itself “smeared” across a band of torque or
power output and cannot be said to represent a single point
value, then a small range of torque requirements exist in which
the physiological response is fundamentally unpredictable and
highly sensitive to the initial state of the system. In this case,
the CT would behave as a continuous phase transition rather
than a threshold (for a review of these general concepts, see
Gisiger [18]). In other words, in close proximity to CT, severe-
intensity behavior would be observed where heavy-intensity
responses should be seen (<CT), and heavy-intensity responses
where severe-intensity responses would be expected (>CT).
The purpose of the present study was therefore to determine
whether the CT is a sudden threshold or a gradual transition from
heavy to severe-intensity exercise. The specific experimental hy-
pothesis tested was that the CT represents a sudden threshold,
with no gradual transition from heavy- to severe-intensity behav-
ior within the confidence limits associated with the CT.
METHODS
Participants
Twelve healthy participants (7 male, 5 female; mean ± SD:
age, 24.7 ± 4.8 yr; height, 1.74 ± 0.09 m; body mass,
69.1 ± 11.7 kg) provided written informed consent to partici-
pate in the study, which was approved by the ethics committee
of the University of Kent (Prop 10_2017_18), conformed to
the standards set by the Declaration of Helsinki, except for reg-
istration in a database. Participants were instructed to arrive at
the laboratory in a rested state (having performed no strenuous
exercise in the preceding 24 h) and to have consumed neither
any food nor caffeinated beverages in the 3 h before arrival.
Participants attended the laboratory at the same time of day
(±2 h) during each visit.
Experimental Design
Participants were required to visit the laboratory on nine oc-
casions over a 5- to 9-wk period, with a minimum of 48 h be-
tween each visit. During their first visit, participants were
familiarized with all testing equipment and procedures, and
the settings for the dynamometer and stimulator were re-
corded. During visits 2–5, participants performed a series of
intermittent isometric contractions to task failure (Severe Tri-
als). From these four tests, the CT was calculated, and partic-
ipants subsequently performed four further tests, during
visits 6–9, just below and just above the calculated CT
FIGURE 1—The rate of change in potentiated doublet torque as a func-
tion of the CT in two previous studies. The black circles are drawn from
Burnley et al. (2), and the white squares are drawn from Pethick et al.
(5). The dashed lines represent the limits of present observations for sub-
and supra-CT exercise. Note the very slow decline in the potentiated dou-
blet (and thus the slow development of peripheral fatigue) below the CT,
but the increasingly rapid decline in doublet torque above the CT. The
primary aim of the present study was to fill the void between the illus-
trated two dashed lines.







(Circa-CT Trials) for 30 min or until task failure, whichever
occurred sooner. In each trial, torque output was sampled con-
tinuously to allow the quantification of complexity, muscle ac-
tivity was measured using the vastus lateralis electromyogram
(EMG), muscle oxygen consumption (mV̇O2) was measured
using near-infrared spectroscopy (NIRS), and maximal volun-
tary contractions (MVCs) with supramaximal femoral nerve
stimulation were used to quantify global, central, and periph-
eral fatigue.
Dynamometry
During all visits, participantswere seated in the chair of aCybex
isokinetic dynamometer (HUMAC Norm; CSMi, Lawrence,
MA), initialized and calibrated according to the manufacturer’s
instructions. Their right leg was attached to the lever arm of the
dynamometer, with the seating position adjusted to ensure that
the lateral epicondyle of the femur was in line with the axis of
rotation of the lever arm. Participants sat with relative hip and
knee angles of 85° and 90°, respectively, with full extension
being 0°. The lower leg was securely attached to the lever
arm above the malleoli with a padded Velcro strap, whereas
straps secured firmly across both shoulders and the waist
prevented any extraneous movement and the use of the hip ex-
tensors during the isometric contractions. The seating position
was recorded during the first visit and replicated during each
subsequent visit.
Femoral Nerve Stimulation
Electrical stimulation of the right femoral nerve was used to
assess neuromuscular fatigue processes, in the same way as
described by Pethick (12). The anode, a carbon rubber elec-
trode with adhesive gel (100  50 mm; Phoenix Healthcare
Products Ltd., Nottingham, United Kingdom), was placed lat-
eral to the ischial tuberosity, on the posterior aspect of the leg.
The position of the cathode was established using a motor
point pen (Compex; DJO Global, Guildford, United Kingdom)
and determined based on the location in the femoral triangle,
giving the largest twitch and greatest peak-to-peak amplitude
of the compound muscle action potential (M-wave) after sin-
gle stimulation at 100 mA, using a constant-current variable
voltage stimulator (Digitimer DS7AH, Welwyn Garden City,
United Kingdom). After the establishment of the precise cat-
hode location, an Ag/AgCl electrode (32  32 mm; Nessler
Medizintechnik, Innsbruck, Austria) coated in conductive gel
was placed over the femoral nerve.
The appropriate stimulator current was then established by
incrementally increasing the current (in steps of 20 mA) until
knee extensor torque and the M-wave response to single
twitches had plateaued. This was verified with stimulation de-
livered during a contraction at 50%MVC to ensure a maximal
M-wave during an isometric contraction was also evident. Once
this was obtained, the stimulator current was then increased to
130% of the current producing amaximalM-wave (mean ± SD,
338 ± 88 mA). In all subsequent trials, doublet stimulation (two
200-μs pulses with 10-ms interpulse interval) was used.
Surface EMG
The EMG of the vastus lateralis was sampled using Ag/
AgCl electrodes (32  32 mm; Nessler Medizintechnik). Be-
fore attachment of the electrodes, the skin of the participants
was shaved, abraded, and then cleaned with an alcohol swab
over the belly of the muscle, in order to reduce impedance.
The electrodes were placed on the prepared skin over the belly
of the muscle in a direction parallel to the alignment of the
muscle fibers. A reference electrode was placed on the prepared
skin medial to the tibial tuberosity. Care was taken to ensure
that the electrode locations were similar between sessions by vi-
sual inspection and palpation of the muscle belly during a light
contraction. The raw EMG signals were sampled at 1 kHz, am-
plified (gain 1000) and band-pass filtered (10–500 Hz; Biopac
MP 150; Biopac Systems Inc., Goleta, CA).
Muscle Oxygen Consumption
The mV̇O2 from the vastus lateralis was obtained using a
continuous-wave NIRS device (OxymonMk III; Artinis Med-
ical Systems, Elst, the Netherlands), calibrated according to
the manufacturer’s instructions before each trial. The NIRS
device generated light at three wavelengths (905, 850, and
770 nm) corresponding to the absorption wavelengths of oxy-
hemoglobin (O2Hb) and deoxyhemoglobin (HHb). An area at
the level of the largest circumference of the vastus lateralis was
shaved, abraded, and cleaned with an alcohol swab. The NIRS
optode was then placed at this location and secured with Velcro
straps and biadhesive tape, such that the optode did not move
during contraction. A blood pressure cuff (Hokanson E20 cuff
inflator; D.E. Hokanson Inc., Bellevue, WA) was placed prox-
imal to the NIRS optode and was used to maintain blood vol-
ume under the optode during measurement. NIRS data were
collected at 10 Hz. Adipose tissue thickness at the site of mea-
surement was assessed, as per the recommendations of Ferrari
et al. (19), using skinfold calipers. However, as demonstrated
by Ryan et al. (20), an ischemic calibration eliminates any effect
of adipose tissue thickness and scales the NIRS signals accord-
ing to the maximal physiological range.
Protocol
All visits followed a pattern of data acquisition similar to
that previously reported (21). Each visit began with the instru-
mentation of the participants and the establishment of the correct
dynamometer seating position and supramaximal stimulation re-
sponse. Participants then performed a series of brief (3-s) MVCs
to establish their maximal torque. These contractions were
separated by a minimum of 60-s rest and continued until the
peak torques in three consecutive contractions were within
5% of each other. Participants were given a countdown, followed
by very strong verbal encouragement to maximize torque. The
first MVC was used to establish the fresh maximal EMG signal,
against which the subsequent EMG signals were normalized
(Data Analysis). The second and third MVCs were performed
with femoral nerve stimulation delivered during the contraction










and at rest after the contraction. The stimulation during the
contraction was delivered during a plateau in maximal torque,
in order to test the maximality of the contraction and provide
the resting voluntary activation, whereas the stimulation at rest
was delivered 2 s after the contraction, in order to establish the
fresh potentiated doublet torque. All subsequent contractions
with femoral nerve stimulation were conducted in this manner.
After the establishment of maximal torque, the resting
mV̇O2 of the vastus lateralis was assessed based on the de-
crease in muscle oxygenation, which accompanies an arterial
occlusion (20,22). For this, the blood pressure cuff was inflated
to 300 mm Hg using a Hokanson AG101 (D.E. Hokanson Inc.).
Four resting measurements were made using 10 s of arterial
occlusion, each separated by 60-s rest. The resting mV̇O2
was calculated using linear regression with the first 8 s of each
occlusion (Data Analysis). Participants then rested for 10min be-
fore performing the experimental trial (see below).
Severe Trials
During visit 2 (the first of the severe trials), the highest in-
stantaneous pretest measure of voluntary torque was recorded
as the peak MVC torque, and the target torques for the sub-
maximal contractions in visits 2–5 were calculated from this
value. The submaximal contractions were performed, as in
our previous studies (5,12) using a duty cycle of 0.6, with con-
tractions held for 6 s, followed by 4-s rest. The target for the
submaximal contractions in visit 2 was set at 50% of the peak
torque measured in the pretest MVCs. Participants were
instructed to match their instantaneous torque with a target
bar superimposed on the display in front of them and were re-
quired to continue matching this torque for as much of the 6-s
contraction as possible. The test was conducted until task fail-
ure, the point at which the participant failed to reach the target
torque on three consecutive contractions, despite strong verbal
encouragement. Participants were not informed of the elapsed
time during the test, but were informed of each “missed” con-
traction. After the third missed contraction, participants were
instructed to produce an MVC, which was accompanied by
peripheral nerve stimulation.
At the end of eachminute (i.e., after every fifth contraction),
mV̇O2 was assessed, as described by Pethick et al. (21). The
blood pressure cuff was inflated to 300 mm Hg for 5 s, with
mV̇O2 calculated using linear regression over the course of
this occlusion. This measure of mV̇O2 was performed instead
of a targeted contraction. mV̇O2 was also assessed immedi-
ately before the MVC performed at task end/failure. Five mi-
nutes after task end/failure, an ischemia/hyperemia calibration
was performed to normalize the NIRS signals. The blood pres-
sure cuff was inflated to 300 mm Hg for 3–5 min (or until the
NIRS signals plateaued). This deoxygenated the tissue under
the optode (defined as 0% oxygenation), whereas the peak hy-
peremic response upon release of the cuff was assigned a
value of 100% oxygenation.
The duration of the initial severe trial at 50%MVCwas used
to determine the percentage of MVC used in the subsequent
three trials, which were performed in an identical manner. The
objective of these trials was to yield times to task failure of be-
tween 2 and 15 min, which have been recommended for the
assessment of CT (23). The subsequent severe trials were per-
formed in a randomized order. Visits 2–5 were used to deter-
mine the CT. The individual trials were identified as severe 1
(S1) to severe 4 (S4), with S1 and S4 being the lowest and
highest torques, respectively.
Circa-CT Trials
The final four visits were performed at target torques based
on the SE of the calculated CT. The target torques were two
SE below the CT (CT − 2), one SE below the CT (CT − 1),
one SE above the CT (CT + 1), and two SE above the CT
(CT + 2). Thus, by design, each of these trials was within
the 95% confidence limits of the CT parameter estimate, but
below or above the point estimate. These trials were conducted
in the same manner as the severe trials, requiring participants
to perform intermittent contractions (6-s on, 4-s off ) at a target
torque. In these trials, the contractions were performed for
30 min or until task failure, whichever occurred sooner. These
four circa-CT trials were performed in a randomized order. No
trials were performed exclusively below CT because of the al-
ready heavy time commitment on the part of the participants
(nine laboratory visits of up to 2 h each), so as to maximize
the granularity of the circa-CT analysis. As a result, the re-
sponses to the circa-CT trials were compared with our previ-
ously published studies (Fig. 1) to establish whether those
response profiles approximated heavy exercise.
Data Acquisition and Participant Interface
Data acquisition was performed in a similar manner as pre-
viously described (21). Briefly, the isokinetic dynamometer,
stimulator and EMG were connected via BNC cables to a
Biopac MP150 (Biopac Systems Inc.) and a CED Micro
1401–3 (Cambridge Electronic Design, Cambridge, United
Kingdom) interfaced with a personal computer. These data
were sampled at 1 kHz and collected in Spike2 (Version 7;
Cambridge Electronic Design). The NIRS data were sampled
at 10 Hz and collected in OxySoft (Artinis Medical Systems).
A chart containing the instantaneous torque was projected
onto a screen placed ~1 m in front of the participant. A scale
consisting of a thin line (1 mm thick) was superimposed on
the torque chart and acted as a target, so that participants were
able to match their instantaneous torque output to the target
torque during each visit.
Data Analysis
All data were analyzed using a code written in MATLAB
R2017a (The MathWorks, Natick, MA). The data analysis fo-
cused on five areas: 1) basic measures of torque and EMG,
2) calculation of CT, 3) measures of central and peripheral fa-
tigue, 4) the variability and complexity of torque output, and
5) measures of mV̇O2.







Torque and EMG. The mean and peak torque for each
contraction in each trial were determined. The mean torque
was calculated based on the steadiest 5 s of each contraction,
with MATLAB code identifying the 5 s of each contraction
with the lowest SD. The point of task failure was determined
as described previously (12). The mean torque produced dur-
ing the first five contractions was calculated, with task failure
deemed to occur when the mean torque recorded during three
consecutive contractions was more than 5 N·m below the
mean torque of the first five contractions, with the first of these
contractions being considered the point of task failure.
The EMG output from the vastus lateralis for each contrac-
tion was full-wave rectified during each 5-s window. The average
rectified (arEMG) was then calculated and normalized by express-
ing the arEMG as a fraction of the arEMG obtained during an
MVC from the fresh muscle performed at the beginning of the trial.
CT. CT was determined as in Pethick et al. (5). The total
torque impulse produced until task failure and the total contrac-
tion time during each individual trial were calculated. The torque
impulse was then plotted against the contraction time, and the
parameters of the torque–duration relationship were estimated
using linear regression of the torque impulse versus contrac-
tion time (2):
torque impulse ¼ W ′ þ CT t ½1
where W′ represents the curvature constant parameter and t is
the time to task failure.
Central and peripheral fatigue. Measures of central
and peripheral fatigue were calculated based on the stimuli de-
livered during and after the MVCs performed pretest and at
task end/failure. Peripheral fatigue was evidenced by a fall in
the potentiated doublet torque. Central fatigue was evidenced
by a decline in voluntary activation, quantified using the twitch
interpolation technique (24,25):
voluntary activation %ð Þ
¼ 1 − superimposed doublet=resting doubletð Þ  100 ½2
where the superimposed doublet was that measured during the
contraction of interest and the potentiated doublet was mea-
sured at rest 2 s after that contraction.
Variability and complexity. All measures of variability
and complexity were calculated using the steadiest 5 s of each
contraction, identified by MATLAB as the 5 s containing the
lowest SD. The amount of variability in the torque output of
each contraction was measured using the SD and coefficient
of variation (CV). The SD provides a measure of the absolute
amount of variability in a time series, whereas the CV provides
a measure of the amount of variability in a time series normal-
ized to the mean of the time series.
The temporal structure, or complexity, of torque output was
examined using multiple time domain analyses. The regularity
of torque output was determined using approximate entropy
(ApEn) (26), and the temporal fractal scaling of torque was es-
timated using the detrended fluctuation analysis (27) α scaling
exponent (DFA α). The calculations of ApEn and DFA are
detailed in the study by Pethick et al. (21). In brief, ApEn
was calculated with the template length, m, set at 2 and the
tolerance, r, set at 10% of the SD of torque output, and DFA
was calculated across time scales (57 boxes ranging from
1250 to 4 data points). If crossover in the DFA analysis was
identified in the log–log plot of fluctuation size versus box size
(as shown by an r < 0.95), an iterative piecewise least squares
linear regression was used to fit two lines to the plot for these
trials, and two α exponents were quantified. The second of
these (α2, representing longer, physiologic timescales) was
used in the DFA α exponent analysis (21). Ten cases of cross-
over occurred during the circa-CT trials (out of 48 trials) and
none during the severe-intensity predicting trials.
Muscle oxygen consumption. mV̇O2 was determined
as described by Ryan et al. (20,22). mV̇O2 was calculated as
the slope of the change in O2Hb and HHb during arterial oc-
clusion using simple linear regression. The restingmV̇O2mea-
surement was based on the first 8 s (80 data points) of a 10-s
arterial occlusion, whereas the exercising mV̇O2 measure-
ments were based on a 5-s arterial occlusion (50 data points).
The NIRS data were corrected for blood volume changes
(20,22) using custom-written MATLAB code. A blood vol-
ume correction factor (β) was calculated for each data point
during the arterial occlusions:
β tð Þ ¼ O2Hb tð Þj j
O2Hb tð Þj j þ HHb tð Þj jð Þ ½3
where β is the blood volume correction factor, t is time, O2Hb
is the oxygenated hemoglobin/myoglobin signal, and HHb is
the deoxygenated hemoglobin/myoglobin signal. Each data
point was corrected using its corresponding β according to
Eqs. 4 and 5, as follows:
O2Hbc tð Þ ¼ O2Hb tð Þ− tHb tð Þ  1− βð Þ½  ½4
HHbc tð Þ ¼ HHb tð Þ − tHb tð Þ  β½  ½5
where O2Hbc and HHbc are the corrected oxygenated and de-
oxygenated hemoglobin/myoglobin signals, respectively; tHb
is the blood volume signal from the NIRS device; β is the
blood volume correction factor; and t is time. The raw O2Hb
signal in equation 4 is corrected by subtracting the proportion
of the blood volume change attributed to O2Hb, whereas in
equation 5, the raw HHb signal is corrected by subtracting
the proportion of blood volume change attributed to HHb.
Rates of Change
To identify heavy- or severe-intensity behavior in mV̇O2,
arEMG and fatigue and complexity-related variables, we first
calculated the rate of change in CT − 2 from the secondminute
of exercise until task failure or task completion (30 min)—in
order to avoid contamination of the primary kinetics of
mV̇O2—and compared this with the equivalent rates of change
in all other circa-CT trials. Specifically, the rate of change in
CT − 2 for each individual participant was subtracted from
their rates of change in each other condition, assuming that










CT − 2 most likely represented heavy-intensity exercise.
Severe-intensity exercise was then deemed to have occurred
if the resulting “normalized” rate of change was 2 SD greater
than that individual’s CT − 2 value, where the SD was the
SD of the rate of change in CT − 2 (as reported in Tables 1
and 2). Thus, if a participant’s responses to CT − 1, CT + 1,
and CT + 2 exceeded the 2-SD criterion, they were considered
severe intensity, but if below it, they were considered heavy.
We accept that this value is arbitrary, but in the absence of
any agreed quantitative definition of heavy-intensity behavior,
we suggest that this “2 σ” approach provides an objective and
justifiable metric. Using criterion values greater than 2 SD is
likely to result in misclassification (i.e., misclassifying
severe-intensity exercise as heavy).
Statistics
All data are presented as means ± SD unless otherwise
stated. The S4 trial was used only for the purposes of deter-
mining CT and was excluded from all further analysis. This
was due to its relatively short duration making the calculation
of rates of change impossible. Two-wayANOVAwith repeated
TABLE 1. Voluntary torque, potentiated doublet torque, and voluntary activation during contractions within the confidence limits of (CT − 2, CT − 1, CT + 1, and CT + 2) and above (S1–S3) the CT.
Parameter CT − 2 CT − 1 CT + 1 CT + 2 S1 S2 S3
Target torque, N·m 57.2 ± 15.1 59.3 ± 15.1 63.5 ± 15.3 65.6 ± 15.5 85.5 ± 21.6 97.4 ± 25.0 112.2 ± 26.5
Target torque, % MVC 24.8 ± 3.1 25.7 ± 3.0 27.6 ± 3.0 28.6 ± 3.0 37.1 ± 3.5 42.1 ± 3.3 48.8 ± 3.1
Time to task end/failure, min 30.0 ± 0.0 30.0 ± 0.0 30.0 ± 0.0 29.5 ± 1.7 16.8 ± 2.8 9.7 ± 1.2 6.2 ± 0.9
Global fatigue
Preexercise MVC, N·m 245.8 ± 65.8 245.7 ± 71.1 247.2 ± 63.5 243.3 ± 63.5 236.3 ± 71.3 233.6 ± 62.1 233.9 ± 66.6
Peak MVC task end, N·m 197.8 ± 47.4 189.4 ± 58.6 172.2 ± 55.4 156.9 ± 56.7a 106.5 ± 44.0a 112.7 ± 45.2a 127.7 ± 41.5a
Mean MVC task end, N·m 167.6 ± 42.9b,c 162.1 ± 54.9c 147.1 ± 49.2b,c 133.3 ± 50.4b,c 86.0 ± 35.0b 98.8 ± 41.1b 108.7 ± 38.9b
ΔMVC/Δt, N·m·min−1 −1.5 ± 0.8 −1.7 ± 0.7 −2.4 ± 0.9a −2.9 ± 1.7 −7.9 ± 2.5a −12.5 ± 3.4a −17.1 ± 6.6a
Peripheral fatigue
Preexercise doublet, N·m 93.5 ± 31.1 99.1 ± 33.0 96.7 ± 31.9 93.1 ± 27.0 94.4 ± 32.3 94.0 ± 28.4 91.2 ± 33.4
Doublet task end, N·m 87.7 ± 29.2b 92.9 ± 32.6b 83.9 ± 28.3b 79.8 ± 25.3a,b 66.4 ± 23.5a,b 67.6 ± 27.2a,b 65.6 ± 27.2a,b
% Change task end 6.0 ± 4.8 6.4 ± 4.9 13.3 ± 3.7 14.2 ± 6.9 29.3 ± 9.0 29.4 ± 20.6 27.5 ± 7.5
Δdoublet/Δt, N·m·min−1 −0.2 ± 0.2 −0.2 ± 0.2 −0.4 ± 0.2a −0.4 ± 0.3a −1.7 ± 0.8a −2.7 ± 1.1a −4.3 ± 2.6a
Central fatigue
Preexercise VA, % 95.5 ± 3.7 94.7 ± 2.6 94.5 ± 3.4 94.7 ± 3.4 94.9 ± 2.7 93.3 ± 2.6 93.8 ± 3.0
VA task end, % 92.2 ± 3.6b 90.9 ± 5.1 84.9 ± 7.2b 85.6 ± 9.0b 77.1 ± 10.8a,b 80.5 ± 9.2a,b 80.3 ± 8.3a,b
% Change task end 3.5 ± 3.0 3.9 ± 4.6 10.1 ± 7.1 9.6 ± 9.0 18.8 ± 11.2 13.6 ± 10.6 14.6 ± 7.3
ΔVA/Δt, %/min −0.1 ± 0.1 −0.1 ± 0.1 −0.3 ± 0.2 −0.3 ± 0.3 −1.1 ± 0.7a 1.3 ± 1.0a −2.3 ± 1.2a
Values are means ± SD.
Symbols indicate a statistically significant difference compared with CT − 2, value at task beginning, and target torque.
aCT − 2 (P < 0.05).
bValue at task beginning.
cTarget torque.
Δ, change; t, time; VA, voluntary activation.
TABLE 2. EMG amplitude, muscle oxygen uptake, variability, complexity, and fractal scaling responses during contractions within the confidence limits of (CT – 2, CT − 1, CT + 1, and CT + 2) and
above (S1–S3) the CT.
Parameter CT – 2 CT − 1 CT + 1 CT + 2 S1 S2 S3
arEMG start, % MVC 27.3 ± 7.2 27.3 ± 5.6 32.0 ± 9.0 32.5 ± 6.6 42.4 ± 7.6 47.4 ± 8.7 61.6 ± 12.7
arEMG task end, % MVC 31.5 ± 8.1 34.8 ± 8.7 41.9 ± 12.0a,b 48.4 ± 18.2a,b 68.7 ± 17.2a,b 73.4 ± 13.9a,b 80.8 ± 10.8a,b
ΔarEMG/Δt, % MVC/min 0.2 ± 0.2 0.3 ± 0.3 0.4 ± 0.3b 0.6 ± 0.6 1.8 ± 1.1b 3.5 ± 1.4b 4.8 ± 3.2b
mV̇O2 start, %·s
−1 1.65 ± 0.70 1.86 ± 0.80 2.24 ± 0.98 2.45 ± 0.87 2.43 ± 0.99 2.64 ± 1.12 2.60 ± 0.96
mV̇O2 at task end, %·s
−1 1.98 ± 1.00a 2.07 ± 0.92a 2.67 ± 1.12a,b 3.10 ± 0.85a,b 3.27 ± 1.21a,b 3.57 ± 1.21a,b 3.33 ± 0.94a,b
ΔmV̇O2/Δt, %·s
−1 0.01 ± 0.01 0.01 ± 0.01 0.02 ± 0.01 0.03 ± 0.01 0.06 ± 0.02b 0.12 ± 0.08b 0.19 ± 0.08b
SD
SD at task beginning, N·m 1.33 ± 0.45 1.30 ± 0.44 1.37 ± 0.32 1.33 ± 0.32 1.87 ± 0.54 2.24 ± 0.51 2.95 ± 1.07
SD at task failure, N·m 1.64 ± 0.62a 1.55 ± 0.37a 1.87 ± 0.49a 1.90 ± 0.80a 4.71 ± 2.34a,b 7.71 ± 1.21a,b 7.85 ± 2.81a,b
ΔSD/Δt, N·m·min−1 0.01 ± 0.01 0.01 ± 0.01 0.02 ± 0.01 0.02 ± 0.03 0.19 ± 0.13b 0.43 ± 0.35b 1.20 ± 0.59b
CV
CV at task beginning, % 2.30 ± 0.68 2.27 ± 0.66 2.13 ± 0.41 2.03 ± 0.47 2.30 ± 0.65 2.43 ± 0.64 2.66 ± 0.61
CV at task failure, % 2.77 ± 1.04a 2.65 ± 0.55a 2.98 ± 0.66a 2.84 ± 1.18a 6.01 ± 2.16a,b 7.71 ± 1.21a,b 8.29 ± 4.24a,b
ΔCV/Δt, %/min 0.02 ± 0.02 0.01 ± 0.02 0.03 ± 0.02 0.03 ± 0.01 0.21 ± 0.14b 0.48 ± 0.30b 1.38 ± 0.94b
ApEn
ApEn at task beginning 0.56 ± 0.17 0.60 ± 0.24 0.55 ± 0.19 0.56 ± 0.14 0.46 ± 0.15 0.41 ± 0.14 0.32 ± 0.07
ApEn at task failure 0.51 ± 0.18a 0.54 ± 0.19a 0.45 ± 0.10a 0.44 ± 0.17a 0.16 ± 0.09a,b 0.15 ± 0.07a,b 0.07 ± 0.03a,b
ΔApEn/Δt −0.002 ± 0.002 −0.002 ± 0.003 −0.001 ± 0.01 −0.005 ± 0.004 −0.02 ± 0.01b −0.03 ± 0.01b −0.6 ± 0.3b
DFA α
DFA α at task beginning 1.40 ± 0.06 1.38 ± 0.10 1.39 ± 0.06 1.37 ± 0.07 1.40 ± 0.06 1.40 ± 0.05 1.45 ± 0.05
DFA α at task failure 1.35 ± 0.10a 1.22 ± 0.25a 1.22 ± 0.25a 1.33 ± 0.17 1.56 ± 0.04a,b 1.57 ± 0.09a,b 1.65 ± 0.12a,b
ΔDFA α/Δt −0.002 ± 0.003 −0.006 ± 0.008 0.006 ± 0.008 0.001 ± 0.006 0.01 ± 0.01b 0.02 ± 0.02b 0.05 ± 0.04b
Values are means ± SD. Task start values are values from 2 min into exercise, to account for primary amplitude of mV̇O2 response.
Symbols indicate a statistically significant difference compared with the value at task beginning and CT – 2.
aValue at task beginning.
bCT – 2 (P < 0.05).
Δ, change; t, time.







measures was used to test for differences between conditions
and time points, and for a condition–time interaction for MVC
torque, arEMG, potentiated doublet torque, voluntary activa-
tion, variability, complexity, and mV̇O2. The variability, com-
plexity, and mV̇O2 measures were analyzed using means from
the second minute to account for the primary kinetics of the
V̇O2 response (28) and final minute before task end/failure.
When main effects were observed, Bonferroni-adjusted 95%
paired-samples confidence intervals (CI) were used to identify
specific differences. The rates of change in all variables were
analyzed using Student paired-samples t-tests.
RESULTS
Preliminary measures and the CT. The peak instanta-
neous MVC torque recorded during an MVC in visit 2 was
233.4 ± 66.7 N·m. This was used to set the target torques for
the tests performed above CT, which are presented in Table 1.
The CT was calculated to be 61.4 ± 15.2 N·m, which was
equivalent to 26.7% ± 3.0% MVC, and the W′ was
4800 ± 1428 N·m·s. The 95% CI for the estimation of CT
was 8.9 ± 2.8 N·m. The torque requirements for the circa-CT
trials were determined as one or two SE below or above CT
(i.e., within the 95% confidence limits of CT; Table 1).
Torque, muscle oxygen consumption, and EMG.
For the trials above the CT, task failure occurred when partic-
ipants were no longer able to achieve the target torque, despite
a maximal effort. All trials above the CT resulted in significant
decreases in MVC torque (F = 140.80, P < 0.001), with the
mean MVC torque at task failure being not significantly differ-
ent from the torque produced during the submaximal contractions
(Table 1). In contrast, all participants completed 30 min of
contractions (with the exception of one trial in CT + 2) in the
circa-CT trials. At the end of these trials, the meanMVC torque
was still significantly greater than the submaximal torque re-
quirements (95% paired-samples CI = 89.4–131.3 N·m for
CT−2, 74.9–130.6N·m forCT−1, 58.9–108.3N·m forCT+1,
39.5–95.9 N·m for CT + 2), indicating that the contractions
ended with a substantial reserve in maximal torque. MVC torque
remained significantly greater at task end in CT − 2 compared
with task end/failure in CT + 2 (CI = 1.5–67.1 N·m), S1 (CI =
60.9–102.4 N·m), S2 (CI = 44.0–93.6 N·m), and S3 (CI =
39.5–78.2 N·m). The rate of change in MVC torque was
greater for CT + 1 and all severe-intensity trials (S1–S3) com-
pared with CT − 2 (Table 1).
After the initial transient, all of the trials resulted in signifi-
cant increases in mV̇O2 (F = 257.03, P < 0.001; Fig. 2). The
mV̇O2 at task end in CT − 2 remained significantly lower
compared with task end/failure in CT + 1 (CI = −1.6 to
−0.04%·s−1), CT + 2 (CI = −1.7 to −0.6%·s−1), S1 (CI =
−2.2 to −0.3%·s−1), S2 (CI = −2.8 to −0.3%·s−1), and S3
(CI = −2.2 to −0.5%·s−1). The arEMG amplitude increased
over time in all of the trials above CT, reaching ~68% to
80% of the pretest MVC value at task failure (F = 58.30,
FIGURE 2—Groupmean muscle oxygen consumption (A), average rectified EMG (B), ApEn (C), and DFA α exponent (D) responses to contractions close
to and above CT. The four circa-CT trials are represented (CT − 2 to CT + 2), along with the lowest severe-intensity predicting trial (S1). Error bars are
shown only shown at the conclusion of S1, CT − 2, and CT + 2 for clarity (n = 12).










P < 0.001; Fig. 2, Table 2). The circa-CT trials also resulted
in increases in arEMG as the trials progressed, although these
were more modest than for the trials above the CT (Table 1).
The arEMG remained significantly lower at task end in CT − 2
compared with task end/failure in CT + 1 (CI = −15.5% to
−5.2%), CT + 2 (CI = −25.8% to −7.9%), S1 (CI = −49.4%
to −24.5%), S2 (CI = −48.6% to −35.0%), and S3 (CI =
−55.3% to −43.2%). The rates of change for the circa-CT trials
did not differ from CT − 2, whereas all trials above the CT had
greater rates of change than CT − 2 for both mV̇O2 and
arEMG (Table 2). Figure 3 shows the individual rates of
change inmV̇O2 and arEMG normalized to the rates of change
in the CT − 2 trial for the circa-CT trials and S1. None of the
circa-CT demonstrated consistent severe-intensity behavior in
either parameter (defined as a rate of change 2 SD greater than
the CT − 2 mean value), although 1–5 participants exceeded
this threshold value during these trials. The majority of indi-
vidual responses to the S1 trial were correctly classified as
severe-intensity (Figs. 3A, and 3B).
Peripheral and central fatigue. All of the trials above
the CT resulted in significant reductions in potentiated doublet
torque (F = 65.60, P < 0.001; Table 1), indicating the presence
of peripheral fatigue. The circa-CT trials also resulted in mod-
est, though significant, reductions in potentiated doublet
torque (Table 1). The potentiated doublet torque remained sig-
nificantly greater at task end in CT − 2 compared with task
end/failure in CT + 2 (CI = 0.07–15.0 N·m), S1 (CI =
10.7–31.9 N·m), S2 (CI = 3.1–37.2 N·m), and S3 (CI =
5.9–33.3 N·m). Voluntary activation significantly decreased
during all trials above the CT (F = 37.02, P < 0.001; Table 1),
FIGURE 3—Individual rates of change in the muscle oxygen consumption (A), average rectified EMG amplitude (B), ApEn (C), the MVC torque (E), po-
tentiated doublet torque (E), and the DFA α exponent (F) during the circa-CT trials and the S1 trial. In these plots, the rates of change across conditions are
normalized to the CT − 2 condition, thereby eliminating false positives/negatives created by applying sample statistics to the raw individual responses. The
two lines on each panel represent the normalized CT − 2 value and a change of two SD values toward severe-intensity exercise. Severe responses were es-
timated as being greater than 2 SD values from the normalized CT − 2 response (n = 12).







indicating the presence of central fatigue. The circa-CT trials
also resulted inmodest, though significant, decreases in volun-
tary activation (Table 1). Voluntary activation remained sig-
nificantly greater at task end in CT − 2 compared with task
failure in S1 (CI = 8.2%–28.8%), S2 (CI = 6.1%–17.1%),
and S3 (CI = 7.8%–16.6%). There was a greater rate of change
in potentiated doublet torque during CT + 1, CT + 2, and all
other trials above the CT compared with CT − 2. The individ-
ual rates of change in the MVC and potentiated doublet torque
are presented in Figure 3. As previously discussed, for mV̇O2
and arEMG, there were no consistent severe-intensity responses
to the circa-CT trials, although severe-intensity behavior was
inconsistently observed for both variables. In contrast, all par-
ticipants demonstrated correctly classified severe-intensity
responses to the S1 trial.
Variability and complexity. The variability and com-
plexity data are presented in Table 2. The amount of variabil-
ity, as measured by the SD (F = 60.29, P < 0.001) and CV
(F = 78.56, P < 0.001), increased in all trials. The SD and
CV remained significantly lower at task end in CT + 2 com-
pared with task failure in S1 (CI = −5.2 to −0.9 N·m for SD,
−5.4% to −1.1% for CV), S2 (CI = −6.0 to −1.4 N·m for SD,
−5.2% to −1.3% for CV), and S3 (CI = −8.7 to −3.7 N·m for
SD, −9.3% to −1.7% for CV).
Complexity decreased throughout all trials, as measured by
ApEn (F = 132.11, P < 0.001) and DFA α (save CT − 2;
F = 28.98, P < 0.001; Fig. 2, Table 2). ApEn decreased over
the course of all severe trials but remained significantly greater
at task end in CT − 2 compared with task failure in S1 (CI =
0.3–0.5), S2 (CI = 0.2–0.5), and S3 (CI = 0.3–0.6). DFA α in-
creased over the course of all the above CT trials and remained
significantly lower at task end in CT − 2 compared with task
failure in S1 (CI = −0.2 to −0.1), S2 (CI = −0.3 to −0.1), and
S3 (CI = −0.4 to −0.2). There was no difference in the rates
of change between the circa-CT trials, but all trials above CT
showed a greater rate of change than CT − 2 (Table 2). The in-
dividual rates of change are presented in Figure 3. Severe-
intensity behavior was inconsistently observed during the
circa-CT trials for both ApEn and DFA α, but the majority
of cases appeared to be responses in the heavy domain. In con-
trast, all of the responses to S1 were clearly placed in the
severe-intensity domain.
DISCUSSION
The principal original finding of the present study was that
exercise tasks in close proximity to the CT did not show evi-
dence of a sudden fatigue, neuromuscular, metabolic, or phys-
iological complexity threshold at the CT, in contrast to our
first hypothesis. Specifically, we did not observe consistently
severe-intensity behavior in mV̇O2, arEMG, fatigue-related
variables (MVC, potentiated doublet, and voluntary activation),
or torque complexity two SE above the CT (~107% of CT). In
contrast, the lowest severe-intensity task (~139% CT) showed
clear evidence of severe-intensity behavior in the above vari-
ables. Nevertheless, there was some evidence of severe-intensity
responses in some individuals exercising close to the CT, suggest-
ing that the physiological responses to exercise within the confi-
dence limits of the CT are unpredictable. The CT therefore
appears to represent a band of torque values rather than a pre-
cise point estimate, akin to a form of continuous phase transi-
tion between heavy and severe intensity exercise. Thus, we
provide the first evidence that the CT, although representing
a metabolic and fatigue threshold in the context of separating
distinct intensity domains, the transition itself is not sudden
but is rather smeared across a band of torque represented by
the 95% confidence limits of the CT parameter estimate.
Typical responsesobserved in theheavyandsevere-
intensity domains. There is no question that distinct phys-
iological responses can be observed across the exercise intensity
spectrum, with experimentally identifiable physiological land-
marks separating at least four exercise intensity domains
(7,28,29). In previous studies, we have demonstrated that ex-
ercise performed below the CT eventually results in stable
responses (in arEMG), very slowly developing peripheral
fatigue (2), and no change in torque output complexity (5).
For tasks requiring >110% CT, distinctly different fatigue
mechanisms, muscle metabolic responses, and adaptations in
neuromuscular control occur (2,5,8). Specifically, severe-intensity
exercise is characterized by non–steady-state metabolic and
neuromuscular responses, and exercise tolerance is usually
limited to less than ~30 min (e.g., Refs. [2,6,8]). All severe-
intensity trials in the present experiments shared these
characteristics: both mV̇O2 and arEMG increased systemati-
cally until task failure occurred (in less than ~20 min; Fig. 2,
Table 2). The fall in MVC was such that at task failure a max-
imal contraction was required to produce the required torque,
and the potentiated doublet torque had declined to consistently
low values (Table 1). Central fatigue was also evident, with
voluntary activation falling by approximately 10%, consistent
with previously reported responses (2,5). The severe-intensity
trials were also associatedwith substantial reductions in torque
steadiness (torque SD or CV) and torque complexity (ApEn or
DFA α exponent; Table 2, Fig. 2) as previously reported (5).
Behavior in close proximity to theCT.The central aim
of the present study was to determine how these adjustments
behaved in very close proximity to the CT. If the CT is a sud-
den threshold, with the confidence limits simply representing a
fitting error in the linear regression of the torque-time integral
(as a result of variance in severe-intensity performance within
the predicting trials), severe-intensity behavior should have
been absent in all tasks below CT and present in all tasks
above CT. The present study lacked a condition that was de-
monstrably below the CT. This was a deliberate design choice
to focus on the responses within the 95% confidence limits of
the CT while keeping the demands on the participants for re-
peated testing to a minimum (the present experiments required
nine laboratory visits lasting approximately 2 h each). Our pre-
vious work on this issue in comparable cohorts again provides
a useful point of reference (2,5). The responses to the CT − 2
condition in the present study (performed at ~93% CT) were
virtually identical to those responses to a trial at 90% CT










in a study by Pethick et al. (5, their Tables 1 and 2, present
study’s Fig. 4). For example, in our two previous studies, the
rate of fall in potentiated doublet below the CT has never
exceeded 0.9 N·m·min−1. The largest rate of decline in this
variable in CT − 2 was 0.5 N·m·min−1.
In contrast to the severe-intensity responses, the CT − 2 trial
was associated with only small (but statistically significant)
changes in mV̇O2, the MVC, and voluntary activation. Each
of these was significantly smaller in magnitude than those re-
corded in the severe-intensity trials, and at the end of the task
(30 min), there was a significant reserve in torque-generating
capacity (MVC). Similarly, the changes in torque steadiness
and complexity, which were small but statistically significant,
did not reach values observed at task failure in the severe-
intensity trials. Importantly, compared with CT − 2, all severe-
intensity trials showed greater fatigue-related responses at task
failure (in mV̇O2, arEMG,MVC, potentiated doublet, VA, torque
steadiness, and complexity), indicating that the severe-intensity
tasks were performed in a different region of the exercise inten-
sity spectrum than CT − 2. Thus, despite its close proximity to
the CT, all pieces of the evidence, from the present and previous
studies, demonstrate that CT − 2 was performed in the heavy-
intensity domain.
If the CT represents a sudden threshold, then the two trials
performed above the CT (CT + 1 and CT + 2) should have pro-
duced severe-intensity exercise responses. Several parameters
showed statistically significant changes in the CT + 1 and/or
CT + 2 trials compared with CT − 2 (Tables 1, 2). For exam-
ple, MVC and potentiated doublet torque decreased to a greater
degree in CT + 1 and CT + 2 compared with CT − 2 (Table 1),
and mV̇O2 and arEMG were both significantly higher after
30 min above CT compared with CT − 2 (Table 2). In
addition, the rate of increase inmV̇O2was also higher inCT+1
but not CT + 2. Finally, the rate of change inMVC torque was
higher in CT + 1 than CT − 2, and the rate of change in the po-
tentiated doublet, an index of peripheral fatigue, was higher in
both CT + 1 and CT + 2. However, differences between the
CT + 1 and CT + 2 trials compared with CT − 2 would be ex-
pected simply on the basis that the former trials were per-
formed at a higher absolute torque requirement. Of greater
importance is whether or not the responses observed were de-
monstrably in the severe-intensity domain, which would be
expected if the CT is indeed a sudden physiological threshold.
In lieu of a rigorous classification for steady-state and non–
steady-state behavior in the variables measured in the present
study (compare the blood lactate response to exercise) (17),
we attempted to further differentiate heavy- and severe-intensity
exercise by considering any individual rate of change two SD
values greater than that of the mean in CT − 2 to indicate
severe-intensity exercise. These analyses (Fig. 3) revealed that
severe-intensity behavior in mV̇O2, arEMG, MVC, potenti-
ated doublet, and torque complexity could be observed, on oc-
casion, in CT − 1 as well as CT + 1 and CT + 2. Moreover,
responses within an individual sometimes differed across the
circa-CT trials (e.g., severe-intensity behavior being observed
in CT + 1 but not CT + 2; Fig. 3C). Nevertheless, the majority
of participants’ responses in the CT + 1 and CT + 2 trials were
indicative of heavy-intensity domain behavior. In the CT + 2
trial, at most only 3–5 participants produced demonstrably
severe-intensity responses for each variable, and the identity
of these participants also varied. The sensitivity of the individ-
ual analysis is supported by the contrasting results of the S1
analysis: only one response for arEMG and three for mV̇O2
were misclassified as heavy exercise (Figs. 3A and 3B). All
of the fatigue and torque complexity responses were correctly
classified as severe. Such a low occurrence of severe-intensity
responses in the CT + 1 and CT + 2 trials was unexpected,
and thus, these data demonstrated that the CT is not a sudden
threshold. Instead, the confidence limits associated with this
parameter seem to reflect a band of physiological uncertainty,
wherein different system states can coexist and the respo-
nses observed cannot be predicted (i.e., a continuous phase
transition (2,18).
Physiological basis of the phase transition. The data
of the present study demonstrate that the transition from
heavy-intensity to severe-intensity behavior seems to occur
gradually over ~5% of theMVC. This is illustrated in Figure 4,
which presents rate of change in the potentiated doublet torque
in this study and each of our previous investigations of the CT
concept. That such a transition was collectively reflected in
markers of muscle activation, muscle metabolic rate, indices
of neuromuscular fatigue, and torque complexity, with none
of these changes preceding the others implies that the underly-
ing mechanism(s) of this transition is likely to be common to
all of these factors. Importantly, although most responses
within 2 SE of the CT were likely to be characterized as
heavy-intensity exercise, severe-intensity responses were ob-
served, albeit rarely, in all trials. This implies that the
FIGURE 4—The rate of change in potentiated doublet torque as a func-
tion of the CT in the present study, plotted alongside the data from Fig-
ure 1. Data are drawn from Burnley et al. (2) (white circles), Pethick
et al. (5) (white squares) and the present study (black stars). The intensity
of each trial is plotted as a percentage of the CT in that study. Note the in-
crease in the rate of decline in potentiated doublet torque above the CT in
all studies, and the lack of a sudden decline in the potentiated doublet in
close proximity to the CT (shown by the cluster of four stars at the top
of the figure). This suggests that a continuous phase transition, rather than
a threshold, best describes the emergence of severe-intensity behavior
above the CT.







responses to exercise “at” CT/CP (i.e., within the 95% confi-
dence limits of CT/CP) are unpredictable, which is supported
by the inconsistent responses to exercise performed at CP re-
ported previously (6,14,15). It is known that the CP is corre-
lated with the proportion of type I muscle fibers (9), and it
has been shown repeatedly that the CP is sensitive to O2 deliv-
ery (30,31). Moreover, CP is correlated with indices of muscle
capillary density, particularly around type I muscle fibers (13).
Most recently, it has been shown that CP declines after pro-
longed exercise (32), a decline that is blunted by ingestion
of carbohydrates (33). Thus, CT/CP seems to be determined,
in part, by muscle fiber properties and the supply of substrates
and O2 to them, and therefore, the mechanism(s) responsible
for the phase transition we propose here likely involves these fac-
tors too.
It is known that there are spatial and temporal heterogene-
ities in muscle metabolism (34–36) and muscle oxygenation
(37), the latter reflecting the dynamic balance between micro-
vascular O2 delivery and mitochondrial O2 consumption
(Heinonen et al. (38) for review). Thus, those factors above
thought to determine the CP are subject to spatial and temporal
variation in activity and substrate supply.We suggest that such
heterogeneities may also explain the apparent phase transition
that occurs around CT. Specifically, the band of intensities
represented by the CT is, by definition, a region wherein the
neuromuscular system is precariously balanced between heavy
and severe exercise. Subtle variations in motor unit recruitment,
metabolism, and blood flowwithin trials, or between days, may
result in the system being tripped into the severe domain when
it would be expected to be in the heavy domain and vice versa.
Indeed, James and Green (39) produced realistic power–
duration curves during constant load and all-out exercise by
modeling the effect of fatigue on the motor unit pool. The im-
portance of this is that the aforementioned heterogeneities
could increase the probability of motor units developing func-
tionally significant levels of fatigue, leading to the recruitment
of additional, and even less fatigue-resistant motor units. In
other words, the phase transition we propose is a small region
of the intensity spectrum in which the probability of unsustain-
able fatigue and resulting non–steady-state behavior develop-
ing significantly increases. However, it is only in the severe
domain itself (outside the confidence limits of the CT/CP) that
this probability reaches unity.
Limitations. The use of an isometric contraction model
and NIRS-derived measures of mV̇O2 lead naturally to limita-
tions in the extent to which we can generalize the current find-
ings. Specifically, although themV̇O2measures producequalitatively
reasonable profiles of the mV̇O2 response, they represent the
interrogation of a relatively small and superficial volume of the
vastus lateralis (20,22). The same limitation is true for the mea-
surement of arEMG, drawn again from the vastus lateralis. The
use of cuff occlusion to produce these measurements further lim-
ited the present protocol inasmuch as themeasurements of fatigue-
related variables could only take place before and at the immediate
cessation of exercise. We were not able to track the time course
of fatigue, central or peripheral, although such measurements
have been made previously in the heavy and severe domains
(2). Finally, the lack of a condition exclusively in the heavy in-
tensity domain, as mentioned previously, was chosen to limit
the already considerable experimental burden on the participants.
Thus, we had to compare other conditions to the CT − 2 condi-
tion as a proxy for heavy-intensity exercise.We believe that this
choice was justified, as Figure 4 shows that the rate of peripheral
fatigue development was identical to our previous studies in
which contractions were performed demonstrably below the CT.
CONCLUSIONS
The present study demonstrated that the CT is not a sudden
physiological threshold, based on the responses to isometric
contractions within the confidence limits of the CT parameter
estimate. Specifically, when exercise was performed two SE
above the point estimate of CT (~107% of CT), most of the ob-
served responses seemed to be in the heavy-intensity domain.
Such a low occurrence of severe-intensity responses suggests
that the CI values themselves represent a region of physio-
logical uncertainty, which we suggest is caused either by
CT varying day-to-day by an amount represented by the con-
fidence limits or that heterogeneities in muscle recruitment,
metabolism, and/or blood flow can “trip” the system into a
different domain of behavior at any intensity within the con-
fidence limits. In either case, we contend that the CT is most
accurately defined as a continuous phase transition rather
than a sudden threshold. Therefore, to ensure consistent phys-
iological responses, exercise tasks should be performed out-
side the confidence limits associated with the CT or CP
parameter estimate.
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